2021 Cell & Gene Meeting on the Med organized by the Alliance for Regenerative Medicine, was held virtually from Tuesday April 6 – Friday April 9. Cell & Gene Meeting on the Med was a five-day virtual conference featuring more than 120 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies.
Kytopen’s CEO Paulo A. Garcia, Ph.D. presented on our Flowfect® technology, a transformative, platform solution that eliminates the complexity of gene delivery for cell engineering and links discovery, development and manufacturing in one flexible scalable solution. Our goal is to enable simple and efficient non-viral manufacturing of cell therapies in days versus weeks to help patients.